The US has recorded over 2,000 measles cases this year while a leading medical group issued vaccine recommendations that differ from CDC guidance.
Connecticut health officials confirmed the first case of clade I mpox in the United States after a patient traveled to Western Europe.
Researchers at Columbia University have created a two-step RNA therapy that could potentially repair cardiovascular tissue damaged by heart attacks.
Vermont enacted the nation's first state-level ban on paraquat, a weedkilling pesticide linked to increased Parkinson's disease risk.
Demand for egg freezing procedures has increased significantly as women delay childbearing, though the costly treatment remains expensive without insurance coverage.
British inquiry finds COVID vaccine program saved hundreds of thousands of lives but calls for improved support for those who experienced adverse effects.
BBC investigation reveals sleep experts giving advice contrary to NHS guidelines while couple shares stillbirth experience ahead of maternity review.
The World Health Organization has prequalified the first malaria treatment specifically designed for babies, addressing a critical gap in care for newborns.
U.S. military personnel affected by Havana Syndrome are seeking government recognition while reports emerge of lab testing on a potential related device.
California officials charged 21 suspects in a hospice fraud scheme that allegedly defrauded the state of $267 million.
The Soham murderer is on life support with severe head injuries after being attacked by another inmate at HMP Frankland.
Britain's National Health Service will provide Palantir contractors with extensive access to patient data, according to Financial Times reporting.
Health insurer Cigna announced plans to withdraw from ACA marketplaces in 2027, citing marketplace challenges following the end of enhanced federal subsidies.
Federal health officials identify California company Raw Farm's cheddar cheese as likely source of E. coli infections in California, Florida and Texas.
The FDA has granted expanded access to daraxonrasib, an experimental drug for pancreatic cancer patients.
Page 10 of 42 (620 stories)